230 related articles for article (PubMed ID: 2786203)
21. Thymus-dependent antiidiotype and anti-antiidiotype responses to a dinitrophenyl-specific monoclonal antibody.
Baskin JG; Ryan TM; Vakil M; Kearney JF; Lamon EW
J Immunol; 1990 Jul; 145(1):202-8. PubMed ID: 2358673
[TBL] [Abstract][Full Text] [Related]
22. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?
Fagerberg J; Frödin JE; Wigzell H; Mellstedt H
Cancer Immunol Immunother; 1993 Sep; 37(4):264-70. PubMed ID: 8348565
[TBL] [Abstract][Full Text] [Related]
23. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733.
Maruyama H; Benden A; Li W; Zaloudik J; Koido T; Taupin JL; Acres B; Somasundaram R; Prewett M; Herlyn D
Int J Cancer; 1996 Feb; 65(4):547-53. PubMed ID: 8621241
[TBL] [Abstract][Full Text] [Related]
25. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
[TBL] [Abstract][Full Text] [Related]
26. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683
[TBL] [Abstract][Full Text] [Related]
27. Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).
Mellstedt H; Frödin JE; Biberfeld P; Fagerberg J; Giscombe R; Hernandez A; Masucci G; Li SL; Steinitz M
Int J Cancer; 1991 May; 48(3):344-9. PubMed ID: 2040527
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II (AII)-related idiotypic network. II. Heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies.
Budisavljevic M; Geniteau-Legendre M; Baudouin B; Pontillon F; Verroust PJ; Ronco PM
J Immunol; 1988 May; 140(9):3059-65. PubMed ID: 2452197
[TBL] [Abstract][Full Text] [Related]
29. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
30. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
Irvine K; Schlom J
Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
[TBL] [Abstract][Full Text] [Related]
31. Generation of anti-idiotypic and anti-anti-idiotypic monoclonal antibodies in the same fusion. Support of Jerne's Network Theory.
Hébert J; Bernier D; Boutin Y; Jobin M; Mourad W
J Immunol; 1990 Jun; 144(11):4256-61. PubMed ID: 2341720
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II (AII)-related idiotypic network. III. Comparative analysis of idiotopes and paratopes borne by monoclonal antibodies raised against AII (AB1) and its internal image (AB3).
Budisavljevic M; Ronco PM; Verroust PJ
J Immunol; 1990 Sep; 145(5):1440-9. PubMed ID: 2384665
[TBL] [Abstract][Full Text] [Related]
33. Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
Leuk Lymphoma; 1994 May; 13(5-6):429-40. PubMed ID: 8069188
[TBL] [Abstract][Full Text] [Related]
34. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
35. Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A.
Fagerberg J; Ragnhammar P; Liljefors M; Hjelm AL; Mellstedt H; Frödin JE
Cancer Immunol Immunother; 1996 Feb; 42(2):81-7. PubMed ID: 8620524
[TBL] [Abstract][Full Text] [Related]
36. Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones.
Bona CA; Heber-Katz E; Paul WE
J Exp Med; 1981 Apr; 153(4):951-67. PubMed ID: 7252415
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of anti-anti-idiotypic monoclonal antibody ("Ab1-like Ab3") in relation to carcinoembryonic antigen.
Tsujisaki M; Masuya J; Okada Y; Jinnohara T; Sasaki S; Yachi A; Imai K
J Clin Lab Anal; 2002; 16(6):279-89. PubMed ID: 12424800
[TBL] [Abstract][Full Text] [Related]
38. Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotope antibodies.
Chattopadhyay P; Starkey J; Raychaudhuri S
J Immunol; 1991 Sep; 147(6):2055-62. PubMed ID: 1890311
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. I. Role in the anti-S. mansoni antibody response.
Velge-Roussel F; Auriault C; Mazingue C; Capron A
J Immunol; 1991 Dec; 147(11):3960-6. PubMed ID: 1719095
[TBL] [Abstract][Full Text] [Related]
40. The immune response against anti-idiotope antibodies II. The induction of antibodies bearing the target idiotope (Ab3 beta) depends on the frequency of the corresponding B cells.
Tesch H; Takemori T; Rajewsky K
Eur J Immunol; 1983 Sep; 13(9):726-32. PubMed ID: 6413225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
